α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
Cecilia S. Lindestam Arlehamn(La Jolla Institute for Immunology), Alessandro Sette(La Jolla Institute for Immunology), Bjoern Peters(La Jolla Institute for Immunology), David Sulzer(Columbia University Irving Medical Center), Rebecca Kuan(La Jolla Institute for Immunology), April Frazier(La Jolla Institute for Immunology), Juliana Rezende Dutra(Columbia University Irving Medical Center), Jennifer G. Goldman(School of the Art Institute of Chicago), Amy W. Amara(University of Alabama at Birmingham), S. Mallal(Vanderbilt University Medical Center), Rekha Dhanwani(La Jolla Institute for Immunology), Elizabeth J. Phillips(Murdoch University), Mario Roederer(National Institutes of Health), Karen Marder(Columbia University Irving Medical Center), David G. Standaert(University of Alabama at Birmingham), John Pham(La Jolla Institute for Immunology), Irene Litvan(University of California, San Diego)
Cited by 399
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
|Cell|2020|4k
Novel Mode of Microbial Energy Metabolism: Organic Carbon Oxidation Coupled to Dissimilatory Reduction of Iron or Manganese
|Applied and Environmental Microbiology|1988|2.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k